Israel - English - Ministry of Health

taro international ltd, israel - dobutamine as hydrochloride - solution for infusion - dobutamine as hydrochloride 250 mg / 20 ml - dobutamine - dobutamine is indicated for patients who require a positive inotropic support in the short term treatment of adults with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures, especially when a low cardiac output is associated with raised pulmonary pressure

Malta - English - Medicines Authority

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - dobutamine - concentrate for solution for infusion - dobutamine 12.5 mg/ml - cardiac therapy

Malta - English - Medicines Authority

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - dobutamine - concentrate for solution for infusion - dobutamine 12.5 mg/ml - cardiac therapy

Malta - English - Medicines Authority

claris lifesciences uk limited - dobutamine - concentrate for solution for infusion - dobutamine 12.5 milligram(s)/millilitre - cardiac therapy

Malta - English - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - dobutamine - concentrate for solution for infusion - dobutamine 12.5 mg/ml - cardiac therapy

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - dobutamine hydrochloride - concentrate for soln for inf - 12.5 mg/ml

United States - English - NLM (National Library of Medicine)

hikma farmaceutica - dobutamine hydrochloride (unii: 0wr771djxv) (dobutamine - unii:3s12j47372) -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - dobutamine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - dobutamine hydrochloride, quantity: 14.01 mg/ml (equivalent: dobutamine, qty 12.5 mg/ml) - injection, concentrated - excipient ingredients: sodium metabisulfite; water for injections; hydrochloric acid; sodium hydroxide - dobutamine is indicated for adults who require inotropic support in the treatment of low output cardiac failure associated with organic heart disease, myocardial infarction, open heart surgery, cardiomyophathies, septic shock and cardiogenic shock. dobutamine can increase or maintain cardiac output during positive end expiratory pressure ventilation.

New Zealand - English - Medsafe (Medicines Safety Authority)

hospira nz ltd - dobutamine hydrochloride 14.01 mg/ml equivalent to 12.5 mg/ml dobutamine - solution for injection - 12.5 mg/ml - active: dobutamine hydrochloride 14.01 mg/ml equivalent to 12.5 mg/ml dobutamine excipient: sodium metabisulfite water for injection